Patent · US Active

Nogo receptor antagonists

US8669345B2 · kind B2 · utility

14Cited by

25References

3Claims

0Family size

Assignee

BIOGEN IDEC MA INC. · US

Inventors

Daniel H.S. Lee · Sudbury, US
Dingyi Wen · Waltham, US
R. Blake Pepinsky · Arlington, US
Jane K. Relton · Belmont, US
Xinzhong Wang · Wayland, US
Alexey A. Lugovskoy · Woburn, US
Werner Meier · Burlington, US
Ellen Garber · Cambridge, US
Laura Silvian · Newton, US
Paul H. Weinreb · Andover, US

Key dates

Filing date	Jan 26, 2007
Grant date	Mar 11, 2014
Priority date	—
Expiry date	Jul 24, 2030

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12N2310/53
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Disclosed are immunogenic Nogo receptor-1 polypeptides, Nogo receptor-1 antibodies, antigen-binding fragments thereof, soluble Nogo receptors and fusion proteins thereof and nucleic acids encoding the same. Also disclosed are Nogo receptor antagonist polynucleotides. Also disclosed are compositions comprising, and methods for making and using, such Nogo receptor antibodies, antigen-binding fragments thereof, soluble Nogo receptors and fusion proteins thereof, nucleic acids encoding the same and antagonist polynucleotides.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.